Atherosclerosis solution is likely many years away

While advances have been made in understanding how genetics, metabolism of HDL and LDL cholesterol, the inflammatory process, blood clots, and blood pressure regulation all play a part in the atherosclerosis disease process, a solution is likely many years away and will require huge -- but worthwhile -- investments of time, money and collaboration across fields of study.

It's the leading cause of heart disease and stroke: atherosclerosis--a disease characterized by the thickening of arterial walls, restricting blood flow like a narrow pipe. Preventing and reversing this disease is still largely a puzzle to scientists working to put all the right pieces into place and form a complete picture of health for millions of patients who suffer its devastating effects worldwide.

So notes a University of Kentucky researcher whose perspective is published in the current issue of Nature. Alan Daugherty, director of the University of Kentucky Cardiovascular Research Center, and Dr. Daniel Rader, an endocrinologist and researcher at the University of Pennsylvania, co-authored the article, which offers insight into the complex process of translating scientific discoveries in the laboratory into new therapies for atherosclerosis.

While advances have been made in understanding how genetics, metabolism of HDL and LDL cholesterol, the inflammatory process, blood clots, and blood pressure regulation all play a part in the atherosclerosis disease process, a solution is likely many years away and will require huge--but worthwhile--investments of time, money and collaboration across fields of study. Decisions remain about which drugs to advance to clinical trials and how to measure the success of those therapies, Daugherty and Rader note.

Source: University of Kentucky

Related stories:

Common bacteria activating natural killer T cells may cause autoimmune liver disease
A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Reporting their findings in the May 15 Cell Host & Microbe, the multi-institutional research team said injecting laboratory mice with the bacterium – Novosphingobium aromaticivorans – prompted activation of Natural Killer T (NKT) cells, which were critical to initiating autoimmune processes that led to liver disease.
Vancouver researchers discover missing link between TB bacteria and humans
Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered how tuberculosis (TB) bacteria hide and multiply in the human body and are working toward a treatment to block this mechanism of infection.
Drug therapy for PKU reverses heart damage
A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.
New study shows how T cell's machinery dials down autoimmunity
A St. Jude Children’s Research Hospital study shows that T cells, the body’s master immune regulators, do not use simple on/off switches to govern the cellular machinery that regulates their development and function. Rather, they possess sophisticated molecular controls that enable them to adjust their function with exquisite precision. Such subtle adjustment enables T cells to modulate their development and function, including avoiding autoimmunity.
Elusive protein protects malaria parasite from heme
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have identified Heme Detoxification Protein, a unique protein encoded in the malaria genome that represents a potential target for developing new malaria drugs.
Mothers' high normal blood sugar levels place infants at risk for birth problems
Pregnant women with blood sugar levels in the higher range of normal—but not high enough to be considered diabetes—are more likely than women with lower blood sugar levels to give birth to babies at risk for many of the same problems seen in babies born to women with diabetes during pregnancy, according to a study funded in large part by the National Institutes of Health.
Lab in a Drop
Analysis and diagnosis in a chip format are coming of age, but their practical application has been limited because until now, the sample usually had to be prepared separately and on a nonminiaturized scale. Jürgen Pipper and his team at the Institute of Bioengineering and Nanotechnology in Singapore want to change this.
Combined physical and genetic map finds cancer's 'ignition key'
Whole-organ maps that superimpose genetic information over the terrain of cancerous bladders chart the molecular journey from normal cell to invasive cancer, an international research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports online at the journal Laboratory Investigation, a member of the Nature Publishing Group.

News discussion:

Medicine & Health news